Pedram M. Gerami MD

Dr. Pedram Gerami is the director of the Skin Cancer Institute of Northwestern Medical Group (SCIN-Med) and the director of the Melanoma Program in the Skin Cancer Institute and the Melanoma clinic in the Department of Dermatology. His clinical and research interests are primarily focused on melanoma skin cancer, atypical nevi, and borderline melanocytic tumors such as Spitz tumors which may be difficult to classify. As a dermatologist, dermatopathologist, and researcher focused on the care of patients with melanoma and atypical nevi, he has a unique perspective on the behavior of melanocytic neoplasms. His interests include how to utilize clinical, histologic, and molecular diagnostic methods to optimize diagnostic accuracy and best predict the behavior of melanocytic neoplasms as well as developing methods for diagnosis of melanoma skin cancer at its earliest and most curable stage. In the clinic, he primarily cares for patients with melanoma or atypical nevi. He is recognized internationally for his expertise in the clinical and histologic diagnosis of melanoma. His expertise in the pathologic diagnosis of melanoma draws over 1500 second-opinion cases both from within and outside of the United States per year. As a researcher, he is focused on developing newer molecular-based methods to help distinguish melanoma from nevi and predict the behavior of melanoma and develop methods for diagnosis of melanoma at the earliest possible stage.